잔류 DNA 검사 시장 규모, 점유율 및 동향 분석 보고서 : 제품 유형 및 서비스별, 검사 유형별, 기술별, 용도별, 최종사용자별, 지역별 및 부문별 예측(2026-2033년)

Residual DNA Testing Market Summary

The global residual DNA testing market size was estimated at USD 309.3 million in 2025 and is projected to reach USD 525.3 million by 2033, growing at a CAGR of 6.8% from 2026 to 2033. Growth is driven by stricter regulatory requirements, rising biologics and gene therapy production, and advancements in sensitive DNA detection technologies.

Global Residual DNA Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the residual DNA testing market on the basis of product & service, test type, technology, application, end-user, and region.

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Consumables
• Services
• Test Type Outlook (Revenue, USD Million, 2021 - 2033)
• Raw Material Testing
• Bulk Testing
• Final Product Testing
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• PCR
• Threshold Assays
• DNA Probe Hybridization
• Next-Generation Sequencing
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Monoclonal Antibodies
• Vaccines
• Cell & Gene Therapy
• Others
• End-user Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical and Biotechnology Companies
• Academic & Research Institutes
• CROs & CMOs
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Service Segment
  • 1.2.2. Technology Segment
  • 1.2.3. Test Type Segment
  • 1.2.4. Application Segment
  • 1.2.5. End user Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Residual DNA Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growth of biologics and gene therapies
    • 3.2.1.2. Advancements in detection technologies
    • 3.2.1.3. Increasing R&D and Outsourcing
    • 3.2.1.4. Safety Assurance in Advanced Therapeutics
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced testing technologies
    • 3.2.2.2. Technical challenges in standardization and sensitivity
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenge analysis
• 3.3. Case Study Insights
• 3.4. Residual DNA Testing Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
  • 3.4.2. PESTEL Analysis

Chapter 4. Residual DNA Testing Market: Product & Service Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Residual DNA Testing Market Product & Service Movement Analysis
• 4.3. Global Residual DNA Testing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)
• 4.6. Services
  • 4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Residual DNA Testing Market: Test Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Residual DNA Testing Market Test Type Movement Analysis
• 5.3. Global Residual DNA Testing Materials Market Size & Trend Analysis, by Test Type, 2021 to 2033 (USD Million)
• 5.4. Raw Material Testing
  • 5.4.1. Raw material testing market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Bulk Testing
  • 5.5.1. Bulk testing market estimates and forecasts 2021 to 2033 (USD Million)
• 5.6. Final Product Testing
  • 5.6.1. Final product testing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Residual DNA Testing Market: Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Residual DNA Testing Market Technology Movement Analysis
• 6.3. Global Residual DNA Testing Materials Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 6.4. PCR
  • 6.4.1. PCR market estimates and forecasts 2021 to 2033 (USD Million)
• 6.5. Threshold Assays
  • 6.5.1. Threshold assays market estimates and forecasts 2021 to 2033 (USD Million)
• 6.6. DNA Probe Hybridization
  • 6.6.1. DNA probe hybridization market estimates and forecasts 2021 to 2033 (USD Million)
• 6.7. Next-Generation Sequencing
  • 6.7.1. Next-generation sequencing market estimates and forecasts 2021 to 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Residual DNA Testing Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Residual DNA Testing Market Application Movement Analysis
• 7.3. Global Residual DNA Testing Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 7.4. Monoclonal Antibodies
  • 7.4.1. Monoclonal antibodies market estimates and forecasts 2021 to 2033 (USD Million)
• 7.5. Vaccines
  • 7.5.1. Vaccines market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Cell & Gene Therapy
  • 7.6.1. Cell & gene therapy market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Residual DNA Testing Market: End user Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Residual DNA Testing Market End user Movement Analysis
• 8.3. Global Residual DNA Testing Market Size & Trend Analysis, by End user, 2021 to 2033 (USD Million)
• 8.4. Pharmaceutical & Biotechnology Companies
  • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
• 8.5. CROs & CMOs
  • 8.5.1. CROs & CMOs market estimates and forecasts 2021 to 2033 (USD Million)
• 8.6. Academic & Research Institutes
  • 8.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Residual DNA Testing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2025 & 2033
• 9.2. Regional Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 9.4. North America
  • 9.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 9.5. Europe
  • 9.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Competitive scenario
    • 9.5.7.3. Regulatory framework
    • 9.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key country dynamics
    • 9.5.8.2. Competitive scenario
    • 9.5.8.3. Regulatory framework
    • 9.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5.9. Denmark
    • 9.5.9.1. Key country dynamics
    • 9.5.9.2. Competitive scenario
    • 9.5.9.3. Regulatory framework
    • 9.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Competitive scenario
    • 9.6.4.3. Regulatory framework
    • 9.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Competitive scenario
    • 9.6.5.3. Regulatory framework
    • 9.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Competitive scenario
    • 9.6.6.3. Regulatory framework
    • 9.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Competitive scenario
    • 9.6.7.3. Regulatory framework
    • 9.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
• 9.7. Latin America
  • 9.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
• 9.8. MEA
  • 9.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Competitive scenario
    • 9.8.2.3. Regulatory framework
    • 9.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Competitive scenario
    • 9.8.3.3. Regulatory framework
    • 9.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Competitive scenario
    • 9.8.4.3. Regulatory framework
    • 9.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key country dynamics
    • 9.8.5.2. Competitive scenario
    • 9.8.5.3. Regulatory framework
    • 9.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2025
• 10.4. Company Profiles/Listing
  • 10.4.1. Thermo Fisher Scientific, Inc.
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Merck KGaA
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Charles River Laboratories
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. Eurofins Scientific
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Bio-Rad Laboratories, Inc.
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. QIAGEN N.V.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. F. Hoffmann-La Roche Ltd.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. Maravai LifeSciences
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. FUJIFILM Corporation
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. Sartorius AG
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product benchmarking
    • 10.4.10.4. Strategic initiatives